Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/51178
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2020-02-04T08:42:30Z | - |
dc.date.available | 2020-02-04T08:42:30Z | - |
dc.date.issued | 2017-09 | - |
dc.identifier.citation | Mifsud Buhagiar, L., Grech, A., Serracino Inglott, A., & LaFerla, G. (2017, September). Amitriptyline revisited: pharmacogenetic implications in antidepressant treatment. Poster session presented at the 77th FIP Annual Conference, Seoul, Republic of Korea. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/51178 | - |
dc.description.abstract | A poster presentation regarding amitriptyline and the pharmacogenetic implications in antidepressant treatment. Introduction: An interesting lead of pharmacogenomics is whether drug potential could be maximized through reattribution of medical purpose for drugs in which the balance between efficacy and toxicity has been difficult to strike in the general population. Tricyclic antidepressants (TCAs) are often overlooked in psychiatry on claims of poor tolerability, although cheaper with a potential efficacy advantage. Most data available on TCAs derives from an era when genotyping studies were not available. Aims: To assess whether genotyping is apt to translate biomarkers into individualised treatment with amitriptyline and whether harmonized labelling that allows interpretation of pharmacogenetic data can support in exploiting the benefit of a relatively inexpensive antidepressant. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | University of Malta. Department of Pharmacy | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Pharmacogenetics | en_GB |
dc.subject | Depression, Mental -- Treatment -- Malta | en_GB |
dc.subject | Amitriptyline -- Therapeutic use -- Malta | en_GB |
dc.subject | Amitriptyline -- Research -- Malta | en_GB |
dc.subject | Cytochrome P-450 CYP2D6 | en_GB |
dc.subject | Cytochrome P-450 CYP2C19 | en_GB |
dc.title | Amitriptyline revisited : pharmacogenetic implications in antidepressant treatment | en_GB |
dc.type | presentation | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | N/A | en_GB |
dc.contributor.creator | Mifsud Buhagiar, Luana | - |
dc.contributor.creator | Grech, Anton | - |
dc.contributor.creator | Serracino-Inglott, Anthony | - |
dc.contributor.creator | LaFerla, Godfrey | - |
Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Amitriptyline_revisited_pharmacogenetic_implications_in_antidepressant_treatment_2017.pdf | 630.12 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.